<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">119</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0065</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Association of <italic>LOXL1</italic> polymorphisms with pseudoexfoliation in the Chinese</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Kelvin Y.C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ho</surname><given-names>Su Ling</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thalamuthu</surname><given-names>Anbupalam</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Venkatraman</surname><given-names>Anandalakshmi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Venkataraman</surname><given-names>Divya</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pek</surname><given-names>Don C.K.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aung</surname><given-names>Tin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Vithana</surname><given-names>Eranga N.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><aff id="aff1"><label>1</label>Singapore National Eye Centre, Singapore</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, Tan Tock Seng Hospital, Singapore</aff><aff id="aff3"><label>3</label>Genome Institute of Singapore, Singapore</aff><aff id="aff4"><label>4</label>Singapore Eye Research Institute, Singapore</aff><aff id="aff5"><label>5</label>Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore</aff></contrib-group><author-notes><fn><p>The first two authors contributed equally to this work and are joint first authors.</p></fn><corresp id="cor1">Correspondence to: Dr. Eranga Vithana, Singapore Eye Research Institute, 11 Third Hospital Avenue, Singapore, 168751; Phone: 65-63224542; FAX: 65-63224599; email: <email xlink:href="eranga.n.v@seri.com.sg">eranga.n.v@seri.com.sg</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>04</day><month>6</month><year>2009</year></pub-date><volume>15</volume><fpage>1120</fpage><lpage>1126</lpage><history><date date-type="received"><day>28</day><month>2</month><year>2009</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>Single nucleotide polymorphisms (SNPs) within the lysyl oxidase like-1 gene (<italic>LOXL1</italic>; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>) were found to confer risk to pseudoexfoliation glaucoma (XFG) through the pseudoexfoliation syndrome (XFS) in Nordic, Caucasian, and two Asiatic populations (Indian and Japanese). The prevalence (0.2%&#x02013;0.7%) of XFS in the Chinese is considerably lower compared to Nordic populations. The aim of this study was to determine the association of <italic>LOXL1</italic> in Chinese subjects with XFS/XFG.</p></sec><sec sec-type="methods"><title>Methods</title><p>Chinese subjects with clinically diagnosed XFS/XFG and normal controls were recruited. Genomic DNA was extracted, and the two <italic>LOXL1</italic> SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>) were genotyped by bidirectional sequencing. Allele and genotype frequencies were compared between cases and unrelated controls using <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/~purcell/plink/">PLINK</ext-link>. Linkage disequilibrium (LD) calculations and haplotype association analysis were done using the <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/">Haploview</ext-link> package and <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/~purcell/whap/">WHAP</ext-link> package, respectively.</p></sec><sec><title>Results</title><p>Sixty-two Chinese patients (17 XFG and 45 XFS) and 171 Chinese controls were studied. The G allele of <italic>LOXL1</italic> SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was moderately associated (OR=10.97, p=0.0018) with pseudoxfoliation in the Chinese. The frequency of the G allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was not significantly different in cases compared to controls (p=0.142) in the allelic association test. However, the genotype test showed marginal association for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> (p=0.030). Only three haplotypes were observed (T-G, G-G, and G-A) with G-G as a risk haplotype (p=0.0034) and G-A as a protective haplotype (p=0.00039). T-G, which was a risk haplotype in the Japanese, was not associated with XFG in the Chinese (p=0.124).</p></sec><sec><title>Conclusions</title><p>Polymorphisms in <italic>LOXL1</italic> confer risk to XFS/XFG in the Chinese. The lower incidence of XFS compared to other populations suggests additional genetic or environmental factors to have a major influence on the phenotypic expression of XFS in the Chinese. The G allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> has been shown to be associated with XFS/XFG in all populations studied to date.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Pseudoexfoliation syndrome (XFS) is the most common identifiable cause of open-angle glaucoma worldwide [<xref ref-type="bibr" rid="r1">1</xref>]. It is a condition characterized by abnormal accumulation of microfibrillar deposits on the surfaces of the pupillary border, anterior chamber angle, anterior lens capsule, ciliary body, and zonular fibers [<xref ref-type="bibr" rid="r2">2</xref>]. The prevalence of XFS increases with age [<xref ref-type="bibr" rid="r3">3</xref>], and worldwide prevalence rates have been found to vary in different populations [<xref ref-type="bibr" rid="r4">4</xref>-<xref ref-type="bibr" rid="r8">8</xref>]. XFS has been reported to be uncommon in Chinese people with the prevalence of 0.2% reported in Chinese Singaporean adults aged 40 years and older [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>].</p><p>XFS is associated with ocular [<xref ref-type="bibr" rid="r11">11</xref>] and systemic [<xref ref-type="bibr" rid="r12">12</xref>-<xref ref-type="bibr" rid="r16">16</xref>] manifestations including a reported conversion rate of 44% to pseudoexfoliation glaucoma (XFG) over 15 years [<xref ref-type="bibr" rid="r17">17</xref>]. XFG has a worse prognosis than primary open-angle glaucoma (POAG) with high resistance to medical therapy and rapid progression of glaucomatous optic neuropathy [<xref ref-type="bibr" rid="r18">18</xref>].</p><p>A recent study demonstrated the association of XFS/XFG with three single nucleotide polymorphisms (SNPs), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> (R141L), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> (G153D), and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> (intronic), located in the first exon of the lysyl oxidase-like 1<italic/>gene (<italic>LOXL1</italic>) on chromosome 15q24.1 [<xref ref-type="bibr" rid="r19">19</xref>]. The two non-synonymous SNPs, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> were highly associated with XFG (OR=2.46 and 20.10, respectively). Subsequent studies replicated the association of <italic>LOXL1</italic> SNPs with XFS/XFG in different populations including Caucasians, Germans, Italians, Central Europeans, Indians, and Japanese [<xref ref-type="bibr" rid="r20">20</xref>-<xref ref-type="bibr" rid="r30">30</xref>]. The association of <italic>LOXL1</italic> SNPs seems to be confined to XFS/XFG as studies on POAG patients including the Chinese population did not report any significant association [<xref ref-type="bibr" rid="r31">31</xref>-<xref ref-type="bibr" rid="r34">34</xref>].</p><p>Up to now, only two Asian populations, Indian and Japanese, had reported associations with <italic>LOXL1</italic> and XFS [<xref ref-type="bibr" rid="r26">26</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. While the Indian population showed similar allelic associations with Caucasians, the Japanese, which we reported previously, had a reversal of the risk allele in <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> [<xref ref-type="bibr" rid="r28">28</xref>]. It is unknown if other Asian populations like the Chinese have similar associations of <italic>LOXL1</italic> with XFS. Hence, the aim of our study was to evaluate the hitherto untested association of the <italic>LOXL1</italic> SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> in Singaporean Chinese subjects with XFS/XFG.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study subjects</title><p>Chinese patients with clinically diagnosed XFS/XFG and normal Chinese controls were recruited from two tertiary eye care centers, Singapore National Eye Centre and Tan Tock Seng Hospital, in Singapore. Written informed consent was obtained from all subjects, and the study protocol had the approval of the hospitals&#x02019; ethics committees and was performed according to the tenets of the Declaration of Helsinki.</p><p>All subjects underwent detailed ophthalmic examinations by ophthalmologists that included slit-lamp biomicroscopic examination, gonioscopy, dilated examination of the lens, and funduscopy. Subjects with XFS were defined as those with clinical evidence of pseudoexfoliation at the pupil margin, anterior lens surface, or other anterior segment structures with an intraocular pressure (IOP) of less than 21&#x000a0;mmHg and no clinical evidence of glaucomatous optic neuropathy. Subjects with XFG were defined as those with clinical evidence of XFS and glaucomatous optic neuropathy (defined as loss of neuroretinal rim with a vertical cup:disc ratio of greater than 0.7) with compatible visual field loss. Chinese subjects with a normal anterior segment and optic nerve examination and without clinical signs of XFS/XFG were recruited as controls.</p></sec><sec><title>Genotyping</title><p>Genomic DNA was extracted from peripheral white blood cells of all subjects. The genotypes of <italic>LOXL1</italic> SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> were determined by polymerase chain reaction (PCR) followed by bidirectional sequencing as described previously [<xref ref-type="bibr" rid="r28">28</xref>].</p></sec><sec><title>Statistical analysis</title><p>Fisher&#x02019;s exact tests were used to test the allelic and genotypic associations of all the SNPs with XFG and XFS. Hardy&#x02013;Weinberg equilibrium (HWE) of the genotypic frequencies among cases and separately among the controls was also examined. <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/~purcell/plink/">PLINK</ext-link> [<xref ref-type="bibr" rid="r35">35</xref>] was used to do the Fisher&#x02019;s exact test and the logistic regression adjusting for other covariates and SNPs. Linkage disequilibrium (LD) calculations were done using the <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/">Haploview</ext-link> package [<xref ref-type="bibr" rid="r36">36</xref>]. Haplotype association analysis was performed using the <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/~purcell/whap/">WHAP</ext-link> package [<xref ref-type="bibr" rid="r37">37</xref>]. Joint associations of all the haplotypes (global test) and haplotype specific (HS) associations were performed using this program. The haplotype specific test of association was used to examine the independent effect of any specific haplotype. For this test, none of the haplotypes was used under the null model, and the specific haplotype was entered under the alternative model. A likelihood ratio test was then constructed to assess the significance of the haplotype specific effect. Assuming the highly prevalent haplotype as the base line, each of the other haplotype was also compared with the base-line haplotype using a logistic regression model. The power of our study to detect associations was computed using the <ext-link ext-link-type="uri" xlink:href="http://hydra.usc.edu/gxe/">QUANTO</ext-link> software [<xref ref-type="bibr" rid="r38">38</xref>].</p></sec></sec><sec sec-type="results"><title>Results</title><p>Sixty-two Chinese patients (45 XFS and 17 XFG) and 171 Chinese controls were recruited for the study. The mean age of patients (XFS and XFG) was 74.7&#x000b1;7.7 years (age range from 61 to 93), and for normal controls, the mean age was 67.4&#x000b1;5.6 (age range from 58 to 88). The difference in age between cases and controls was found to be significant (p=5.853x10<sup>&#x02212;10</sup>), but the gender frequencies were not (p=0.8824). The demographic characteristics of the study subjects are shown in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Demographic features of subjects in this study.</title></caption><table frame="hsides" rules="groups"><col width="77" span="1"/><col width="211" span="1"/><col width="147" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Features</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Combined pseudoexfoliation XFS (45) + XFG (17) [n=62]</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Controls (n=171)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Age (years)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mean&#x000b1;SD<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">74.7&#x000b1;7.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">67.42&#x000b1;5.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Range<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">61&#x02013;93<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">58&#x02013;88<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Gender</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Male<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">30 (48.39%)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">80 (46.78%)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female</td><td valign="top" align="left" rowspan="1" colspan="1">32 (51.61%)</td><td valign="top" align="left" rowspan="1" colspan="1">91 (53.22%)</td></tr></tbody></table><table-wrap-foot><p>The demographic features of the 62 Chinese pseudoexfoliation study subjects and 171 controls are shown. The age range and mean age with standard deviation (SD) are shown for each cohort. The difference in age between cases and controls was significant (p=5.853x10<sup>&#x02212;10</sup>), but the gender frequencies were not (p=0.8824; Fisher&#x02019;s exact test). Abbreviations: XFS=pseudoexfoliation syndrome; XFG=pseudoexfoliation glaucoma; n=number of subjects.</p></table-wrap-foot></table-wrap><p>The distribution of the allele frequencies for SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> within <italic>LOXL1</italic> are shown in <xref ref-type="table" rid="t2">Table 2</xref>. The Hardy&#x02013;Weinberg equilibrium was observed in the genotype frequencies for patients and controls. The SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> were in strong linkage disequilibrium (D&#x02019;=1, 95% CI: 0.71&#x02013;1.0). The G allele of SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> of <italic>LOXL1</italic> was moderately associated (OR=10.97, p=0.0018) with pseudoexfoliation in the Chinese while the frequency of the G allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was not significantly different in cases compared to controls (p=0.142). The age- and sex-adjusted OR for developing pseudoexfoliation and for having the G allele at SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was 16.56 (95% CI: 1.86&#x02013;144.93, p=0.012). The genotype analysis showed only a marginal association with <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> (p=0.0304).</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Distribution of <italic>LOXL1</italic> polymorphisms in pseudoexfoliation and control subjects.</title></caption><table frame="hsides" rules="groups"><col width="63" span="1"/><col width="40" span="1"/><col width="67" span="1"/><col width="67" span="1"/><col width="69" span="1"/><col width="74" span="1"/><col width="60" span="1"/><col width="62" span="1"/><col width="71" span="1"/><col width="69" span="1"/><col width="103" span="1"/><thead><tr><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>SNP</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Allele</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Allele count (frequency)</bold><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Allele association (p value)</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>OR</bold>&#x02028;<bold>[95% CI]</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Genotype</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Genotype count (frequency)</bold><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Genotype association (p value)</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>p value</bold>&#x02028;<bold>OR [95% CI]</bold></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>XFS/XFG Cases (n=62)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls (n=171)</bold></th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>XFS/XFG cases (n=62)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls (n=171)</bold></th></tr></thead><tbody><tr><td rowspan="3" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">*G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">65 (0.524)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">152 (0.444)<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">0.142<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">1.38&#x02028;[0.91- 2.08]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G-G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20 (0.323)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">29 (0.169)<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">0.03<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">0.0173**&#x02028;2.33 [1.2&#x02013;4.54]<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59 (0.476)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">190 (0.556)<hr/></td><td valign="top" colspan="1" align="center" rowspan="1">T-G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">25 (0.403)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94 (0.550)<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" colspan="1" align="center" rowspan="1">T-T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">17 (0.274)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48 (0.281)<hr/></td></tr><tr><td rowspan="3" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1 (0.008)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28 (0.082)<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">0.0018</td><td rowspan="3" valign="top" align="center" colspan="1">10.97&#x02028;[1.48- 81.49]</td><td valign="top" align="center" rowspan="1" colspan="1">G-G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61 (0.984)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">143 (0.84)<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">0.0013</td><td rowspan="3" valign="top" align="center" colspan="1">0.0013&#x02028;11.94 [1.59&#x02013;89.78]</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="center" scope="row">*G</td><td rowspan="2" valign="top" align="center" colspan="1">123 (0.992)</td><td rowspan="2" valign="top" align="center" colspan="1">314 (0.918)</td><td valign="top" colspan="1" align="center" rowspan="1">G-A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1 (0.016)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28 (0.16)<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">A-A</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00)</td></tr></tbody></table><table-wrap-foot><p>Allelic and genotype association testing results of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> in <italic>LOXL1</italic> for Chinese cases with combined pseudoexfoliation syndrome and controls are shown. The single asterisk indicates the risk allele of each SNP. The double asterisk indicates the p values and OR values for G-G versus T-G+T-T of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>. Abbreviations: SNP=single nucleotide polymorphism; XFS=pseudoexfoliation syndrome; XFG=pseudoexfoliation glaucoma; n=number of subjects; OR=odds ratio; CI=confidence interval.</p></table-wrap-foot></table-wrap><p>The haplotype analysis of <italic>LOXL1</italic> polymorphisms in pseudoexfoliation and control subjects are shown in <xref ref-type="table" rid="t3">Table 3</xref>. Only three of the four possible haplotypes (T-G, G-G, and G-A) were detected in the haplotype analysis. The G-G haplotype was a risk haplotype (OR=1.92, p=0.0034) while the G-A haplotype was observed to be protective (OR=0.08, p=0.00039). The T-G haplotype was not associated with pseudoexfoliation in the Chinese (p=0.124). The two-locus haplotype frequencies in Chinese, Japanese, and Caucasian that are based on SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> are shown in <xref ref-type="table" rid="t4">Table 4</xref>. We have also calculated the haplotype diversity, a measure of the uniqueness of a particular haplotype in a given population, for cases and controls of the three populations [<xref ref-type="bibr" rid="r39">39</xref>]. Reflecting the fact that only three haplotypes are present, the haplotype diversity values were also similar within the controls of all three populations, although the frequency distribution of haplotypes was somewhat different. The predominance of the T-G haplotype in the Japanese affected with pseudoexfoliation was reflected in the low haplotype diversity value (H=0.102) for this sample. The allele frequencies of the two non-synonymous SNPs of <italic>LOXL1</italic> in different populations are shown in <xref ref-type="table" rid="t5">Table 5</xref>.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Haplotype analysis of <italic>LOXL1</italic> polymorphisms in pseudoexfoliation and control subjects.</title></caption><table frame="hsides" rules="groups"><col width="62" span="1"/><col width="62" span="1"/><col width="62" span="1"/><col width="60" span="1"/><col width="59" span="1"/><col width="101" span="1"/><col width="50" span="1"/><col width="99" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Haplotype frequency</bold><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>HS test* p value</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>OR* [95%CI]</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>p value**</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>OR** [95%CI]</bold></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>XFS/XFG total</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.476<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.556<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.124<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.39 [0.91&#x02013;2.12]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.363<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0034<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.92 [1.25&#x02013;2.96]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.018<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.7 [1.1&#x02013;2.63]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G</td><td valign="top" align="center" rowspan="1" colspan="1">A</td><td valign="top" align="center" rowspan="1" colspan="1">0.008</td><td valign="top" align="center" rowspan="1" colspan="1">0.082</td><td valign="top" align="center" rowspan="1" colspan="1">0.00039</td><td valign="top" align="center" rowspan="1" colspan="1">0.08 [0.01&#x02013;0.62]</td><td valign="top" align="center" rowspan="1" colspan="1">0.031</td><td valign="top" align="center" rowspan="1" colspan="1">0.11 [0.01&#x02013;0.80]</td></tr></tbody></table><table-wrap-foot><p>All haplotypes with frequency greater than 1% in the combined case and control sample are shown in the table. The XFS/XFG total indicates pseudoexfoliation with and without glaucoma. The single asterisk indicates haplotype specific (HS) testing. This test is a comparison of a specific haplotype with the other two. The double asterisk indicates the p values and OR values derived from comparing each haplotype with the base-line haplotype (T-G). p values for HS testing are based on 10,000 permutations. Abbreviations: XFS=pseudoexfoliation syndrome; OR=odds ratio; CI=confidence interval; XFG=pseudoexfoliation glaucoma.</p></table-wrap-foot></table-wrap><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Frequencies of the two-locus haplotype among three different populations.</title></caption><table frame="hsides" rules="groups"><col width="94" span="1"/><col width="62" span="1"/><col width="81" span="1"/><col width="85" span="1"/><col width="80" span="1"/><col width="90" span="1"/><col width="82" span="1"/><col width="85" span="1"/><thead><tr><th rowspan="3" valign="top" align="left" scope="col" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link></th><th rowspan="3" valign="top" align="left" scope="col" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link></th><th colspan="6" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Haplotype frequency</bold><hr/></th></tr><tr><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Chinese</bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Japanese [</bold><xref ref-type="bibr" rid="r28">28</xref><bold>]</bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Caucasian [</bold><xref ref-type="bibr" rid="r21">21</xref><bold>]</bold><hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>XFS/XFG (n=62)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls (n=171)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>XFS/XFG (n=209)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls (n=172)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>XFS/XFG (n=86)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Controls (n=2087)</th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.476<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.556<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.947<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.506<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.22<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.34<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.363<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.039<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.365<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.74<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.51<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.082<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.129<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.15<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Haplotype diversity (&#x000b1;SE)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.511 (&#x000b1; 0.01)</td><td valign="top" align="center" rowspan="1" colspan="1">0.554 (&#x000b1; 0.014)</td><td valign="top" align="center" rowspan="1" colspan="1">0.102 (&#x000b1;0.02)</td><td valign="top" align="center" rowspan="1" colspan="1">0.596 (&#x000b1; 0.014)</td><td valign="top" align="center" rowspan="1" colspan="1">0.404 (&#x000b1;0.037)</td><td valign="top" align="center" rowspan="1" colspan="1">0.602 (&#x000b1;0.004)</td></tr></tbody></table><table-wrap-foot><p>The two-locus haplotype frequencies in the Chinese, Japanese, and Caucasian are shown. Only one example is shown for Caucasians from a Caucasian Australian population for comparison with the two Asiatic populations. The distribution of the T-G, G-G, and G-A haplotypes were significantly different between cases and controls in both the Japanese and Caucasian studies shown here [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. In our present Chinese study, only the G-G and G-A haplotypes were significantly different between cases and controls. Haplotype diversity is also given for each sample. Haplotype diversity is a measure of the uniqueness of a particular haplotype in a given population. The haplotype diversity and its variance were calculated using the formula given within the indicated reference [<xref ref-type="bibr" rid="r39">39</xref>].</p></table-wrap-foot></table-wrap><table-wrap id="t5" position="float"><label>Table 5</label><caption><title>Reported allele frequencies of <italic>LOXL1</italic> polymorphisms in pseudoexfoliation and control subjects among different populations.</title></caption><table frame="hsides" rules="groups"><col width="139" span="1"/><col width="70" span="1"/><col width="95" span="1"/><col width="68" span="1"/><col width="52" span="1"/><col width="66" span="1"/><thead><tr><th rowspan="3" valign="top" align="left" scope="col" colspan="1"><bold>Population</bold></th><th rowspan="3" valign="top" align="center" scope="col" colspan="1"><bold>Phenotype</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Allele frequency</bold><hr/></th><th rowspan="3" valign="top" align="center" scope="col" colspan="1"><bold>Sample size</bold></th><th rowspan="3" valign="top" align="center" scope="col" colspan="1"><bold>References</bold></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>&#x02028;<bold> (G/T)</bold><hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>&#x02028;<bold> (G/A)</bold><hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>G</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>G</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Iceland<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.827<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.987<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">75<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r19">19</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.651<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.847<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14474<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sweden<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.834<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.995<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">199<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r19">19</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.682<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.879<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">198<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">USA Caucasian<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.787<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.939<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r20">20</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.665<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.844<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">235<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Australia<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG, XFS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.78<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.95<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">86<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r21">21</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.66<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.84<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2087<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Europe (German+Italian)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG, XFS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.82<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.965<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">726<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r24">24</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.652<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.851<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">418<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Southern India<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG, XFS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.72<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.92<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r26">26</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.74<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">97<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG, XFS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.053 (T=0.947)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.99<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">209<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r28">28</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.497<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.86<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">172<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.005 (T=0.995)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.995<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r30">30</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.47<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">190<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Singapore (Chinese)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">XFG, XFS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.524<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.992<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Present study<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.444<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.918<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">171<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hong Kong (Chinese)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Controls<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.472<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.876<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">250<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r34">34</xref>]<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">African American</td><td valign="top" align="center" rowspan="1" colspan="1">Controls</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">0.599</td><td valign="top" align="center" rowspan="1" colspan="1">97</td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r31">31</xref>]</td></tr></tbody></table><table-wrap-foot><p>Allele frequencies for the G alleles of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> in pseudoexfoliation cases (with and without glaucoma) and controls among different populations are shown. The allele frequencies are shown for normal Chinese controls from Hong Kong for comparison with our present study. NA: not available.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>Our study showed that the G allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> within <italic>LOXL1</italic> confers a 10 fold risk to XFS/XFG in the Chinese population. Genotype analysis revealed that both non-synonymous SNPs, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, were associated with XFS/XFG, although the latter only marginally. This result for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> can be attributed to the limited power of our study due to small sample size. The estimated power of our study ranged between 30%&#x02013;50%, calculated based on the observed range of allele frequencies, the odds ratios in our data, prevalence of 0.2%, and a 1:3 case-control ratio. Since Thorleifsson et al. [<xref ref-type="bibr" rid="r19">19</xref>] reported the results of a genome-wide association study of XFG, which identified three strongly associated variants of <italic>LOXL1</italic>, other studies have replicated the association of the two non-synonymous variants, R141L (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>) and G153D (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>) in different populations. These <italic>LOXL1</italic> replication studies in various populations have suggested <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> to be the XFS-associated SNP with the G allele being the universally disease risk-associated allele. The association of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> with XFS/XFG is controversial due to several reasons. In all the Japanese studies conducted to date, the disease associated allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was T instead of G as seen in Caucasian or the Scandinavian studies [<xref ref-type="bibr" rid="r27">27</xref>-<xref ref-type="bibr" rid="r30">30</xref>]. In other studies such as the one on an Asian population of Southern Indians, the sample sizes were too small to detect statistically significant associations with <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> [<xref ref-type="bibr" rid="r26">26</xref>]. However the G allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> has been shown to be associated with XFS/XFG in all population studied to date.</p><p>To compare our Chinese haplotype data with haplotype data from a Japanese population and a Caucasian population, we have shown the frequencies of the two-locus haplotype for the three different populations (<xref ref-type="table" rid="t4">Table 4</xref>). Our study data conform more with what has been observed in the Caucasian and the Scandinavian studies than with other Japanese studies, even though Japanese and Chinese populations may have a more recent common population history compared to other populations [<xref ref-type="bibr" rid="r40">40</xref>,<xref ref-type="bibr" rid="r41">41</xref>]. The T-G haplotype, which was the risk haplotype in the Japanese population, was not associated with XFS in the Chinese population in our study. Moreover, the G-G haplotype, which is a risk haplotype in the Chinese as it is in Caucasian and the Scandinavian cohorts, is a protective haplotype in the Japanese. However, the frequencies of the three main haplotypes (T-G, G-G, and G-A) between Chinese and Japanese controls are very similar. The T-G haplotype with a frequency at around 50%&#x02013;55% is the major haplotype in both populations whereas in the Nordic and Caucasian populations, the G-G haplotype is the dominant haplotype [<xref ref-type="bibr" rid="r18">18</xref>-<xref ref-type="bibr" rid="r23">23</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. This discrepancy observed in the risk haplotypes between the Chinese and Japanese may partly be caused by some combination of the effects of other unlinked modifier genes and environmental effects influencing the disease penetrance in these two populations. The haplotype formed by protective alleles (T-A) was also not observed in the Chinese case-control groups, similar to data from other Asian populations (Indian and Japanese) as well as Scandinavian and Caucasian populations [<xref ref-type="bibr" rid="r19">19</xref>-<xref ref-type="bibr" rid="r30">30</xref>].</p><p>We also compared the allele frequencies for the G alleles of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> in pseudoexfoliation cases (with and without glaucoma) and controls among different populations (<xref ref-type="table" rid="t5">Table 5</xref>). The minor allele frequency of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was highest in African Americans. This may reflect geographically varying selective pressures and/or a much older population. The minor allele frequency of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was more stable and considerably lower at approximately 15% in all non-African populations. In comparison, the minor allele frequency of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was higher and more varied across populations. This suggests that the G153D variation may produce more deleterious alteration to the gene product than R141L and that there is higher selection against maintaining this polymorphism in populations than R141L. The high variability of the minor allele frequency of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> may also indicate the influence of factors such as genetic drift on this allele frequency. It is interesting to note that these minor alleles are protective against pseudoexfoliation in all populations studied except in the Japanese where the T allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was associated with disease. The frequency of the G allele for SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> at 0.918 is slightly high in our control cohort. However, another study that investigated the <italic>LOXL1</italic> SNPs in Chinese POAG patients from Hong Kong and Beijing with a larger control cohort found the G allele frequency to be 0.876 in their control group, similar to other Caucasian populations. The higher frequency of the G allele in our Chinese cohort may be related to the small sample size. The control group allele frequencies of the non-synonymous SNPs reported by Gong et al. in another Chinese sample were generally similar to our study and may represent the migration of Southern Chinese to Singapore [<xref ref-type="bibr" rid="r34">34</xref>].</p><p>The prevalence of XFS/XFG varies widely across populations, ranging from 20%&#x02013;25% in the Scandinavian countries of Iceland and Finland [<xref ref-type="bibr" rid="r42">42</xref>,<xref ref-type="bibr" rid="r43">43</xref>] to less than 1% in the Chinese and Japanese [<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>]. Interestingly, the lowest G allele frequency for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> at 0.599 has been observed in the African American population where the XFS/XFG prevalence is low at approximately 0.4% [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r31">31</xref>,<xref ref-type="bibr" rid="r44">44</xref>]. However, dissimilarities in risk allele frequencies across populations alone cannot explain the widely different prevalent rates that are observed. Similar allelic architecture in different populations with widely differing disease prevalence has also been observed [<xref ref-type="bibr" rid="r21">21</xref>]. This suggests other yet unidentified genetic and/or environmental factors independent of <italic>LOXL1</italic> that influence the penetrance of the disease.</p><p>In summary, we found an association of <italic>LOXL1</italic> variants with XFS/XFG in the Chinese. Our study of Chinese subjects with XFS further supports previous reports that the G allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> is the universal risk allele associated with XFS. While we were able to replicate similar results in the Chinese population, other genetic and/or strong environmental factors could be modulating the phenotypic expression of XFS in the Chinese, which results in a lower prevalence of the disease in this population.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by the Translational &#x00026; Clinical Research (TCR) Program Grant [NMRC/TCR/002-SERI/2008] from the National Research Foundation (NRF) of Singapore and by a grant from the Singapore Eye Research Institute, Singapore.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritch</surname><given-names>R</given-names></name></person-group><article-title>Exfoliation syndrome and occludable angles.</article-title><source>Trans Am Ophthalmol Soc</source><year>1994</year><volume>92</volume><fpage>845</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">7886885</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tarkkanen</surname><given-names>A</given-names></name><name><surname>Kivela</surname><given-names>T</given-names></name><name><surname>John</surname><given-names>G</given-names></name></person-group><article-title>Lindberg and the discovery of exfoliation syndrome.</article-title><source>Acta Ophthalmol Scand</source><year>2002</year><volume>80</volume><fpage>151</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11952480</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ringvold</surname><given-names>A</given-names></name></person-group><article-title>Epidemiology of the pseudo-exfoliation syndrome.</article-title><source>Acta Ophthalmol Scand</source><year>1999</year><volume>77</volume><fpage>371</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10463402</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnarsson</surname><given-names>A</given-names></name><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Sverrisson</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name></person-group><article-title>Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables.</article-title><source>Acta Ophthalmol Scand</source><year>2007</year><volume>85</volume><fpage>822</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18028119</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsius</surname><given-names>H</given-names></name></person-group><article-title>Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos and Russians.</article-title><source>Trans Ophthalmol Soc U K</source><year>1979</year><volume>99</volume><fpage>296</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">298430</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Hourihan</surname><given-names>F</given-names></name></person-group><article-title>The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study.</article-title><source>Arch Ophthalmol</source><year>1999</year><volume>117</volume><fpage>1319</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">10532440</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Iwase</surname><given-names>A</given-names></name><name><surname>Araie</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Shirato</surname><given-names>S</given-names></name><name><surname>Kuwayama</surname><given-names>Y</given-names></name><name><surname>Mishima</surname><given-names>HK</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Tomita</surname><given-names>G</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name><name><surname>Kitazawa</surname><given-names>Y</given-names></name><collab>Tajimi Study Group, Japan Glaucoma Society.</collab></person-group><article-title>The Tajimi Study Report No. 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population.</article-title><source>Ophthalmology</source><year>2005</year><volume>112</volume><fpage>1661</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16111758</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Kubota</surname><given-names>T</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Kiyohara</surname><given-names>Y</given-names></name><name><surname>Iida</surname><given-names>M</given-names></name><name><surname>Nose</surname><given-names>Y</given-names></name><name><surname>Ishibashi</surname><given-names>T</given-names></name></person-group><article-title>The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama Study.</article-title><source>J Glaucoma</source><year>2005</year><volume>14</volume><fpage>482</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16276281</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>AL</given-names></name><name><surname>Tang</surname><given-names>WW</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name></person-group><article-title>The prevalence of pseudoexfoliation syndrome in Chinese people.</article-title><source>Br J Ophthalmol</source><year>2004</year><volume>88</volume><fpage>193</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">14736771</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>PJ</given-names></name><name><surname>Seah</surname><given-names>SK</given-names></name></person-group><article-title>The prevalence of psuedoexfoliation sundrome in Chinese people: the Tanjong Pagar Survey.</article-title><source>Br J Ophthalmol</source><year>2005</year><volume>89</volume><fpage>239</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15665360</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naumann</surname><given-names>GO</given-names></name><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>K&#x000fc;chle</surname><given-names>M</given-names></name></person-group><article-title>Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.</article-title><source>Ophthalmology</source><year>1998</year><volume>105</volume><fpage>951</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">9627642</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name></person-group><article-title>Association of pseudoexfoliation sydrome with increased vascular risk.</article-title><source>Am J Ophthalmol</source><year>1997</year><volume>124</volume><fpage>685</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9372724</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ringvold</surname><given-names>A</given-names></name></person-group><article-title>Pseudoexfoliation and aortic aneurysms.</article-title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>2139</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">11448005</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roedl</surname><given-names>JB</given-names></name><name><surname>Bleich</surname><given-names>S</given-names></name><name><surname>Reulbach</surname><given-names>U</given-names></name><name><surname>Rejdak</surname><given-names>R</given-names></name><name><surname>Naumann</surname><given-names>GO</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>Junemann</surname><given-names>AG</given-names></name></person-group><article-title>Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma.</article-title><source>J Neural Transm</source><year>2007</year><volume>114</volume><fpage>571</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17238009</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atalar</surname><given-names>PT</given-names></name><name><surname>Atalar</surname><given-names>E</given-names></name><name><surname>Kilic</surname><given-names>H</given-names></name><name><surname>Abbasoglu</surname><given-names>OE</given-names></name><name><surname>Ozer</surname><given-names>N</given-names></name><name><surname>Aksoyek</surname><given-names>S</given-names></name><name><surname>Ovunc</surname><given-names>K</given-names></name><name><surname>Ozmen</surname><given-names>F</given-names></name><name><surname>Gursel</surname><given-names>E</given-names></name></person-group><article-title>Impaired systemic endothelial function in patients with pseudoexfoliation syndrome.</article-title><source>Int Heart J</source><year>2006</year><volume>47</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16479043</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visontai</surname><given-names>Z</given-names></name><name><surname>Merisch</surname><given-names>B</given-names></name><name><surname>Kollai</surname><given-names>M</given-names></name><name><surname>Hollo</surname><given-names>G</given-names></name></person-group><article-title>Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma.</article-title><source>Br J Ophthalmol</source><year>2006</year><volume>90</volume><fpage>563</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16488931</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeng</surname><given-names>SM</given-names></name><name><surname>Karger</surname><given-names>RA</given-names></name><name><surname>Hodge</surname><given-names>DO</given-names></name><name><surname>Burke</surname><given-names>JP</given-names></name><name><surname>Johnson</surname><given-names>DH</given-names></name><name><surname>Good</surname><given-names>MS</given-names></name></person-group><article-title>The risk of glaucoma in pseudoexfoliation syndrome.</article-title><source>J Glaucoma</source><year>2007</year><volume>16</volume><fpage>117</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">17224761</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schl&#x000f6;tzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Naumann</surname><given-names>GO</given-names></name></person-group><article-title>Ocular and systemic pseudoexfoliation syndrome.</article-title><source>Am J Ophthalmol</source><year>2006</year><volume>141</volume><fpage>921</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">16678509</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Magnusson</surname><given-names>KP</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Stefansdottir</surname><given-names>G</given-names></name><name><surname>Masson</surname><given-names>G</given-names></name><name><surname>Hardarson</surname><given-names>GA</given-names></name><name><surname>Petursson</surname><given-names>H</given-names></name><name><surname>Arnarsson</surname><given-names>A</given-names></name><name><surname>Motallebipour</surname><given-names>M</given-names></name><name><surname>Wallerman</surname><given-names>O</given-names></name><name><surname>Wadelius</surname><given-names>C</given-names></name><name><surname>Gulcher</surname><given-names>JR</given-names></name><name><surname>Thordteinsdottir</surname><given-names>U</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name></person-group><article-title>Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>1397</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">17690259</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Challa</surname><given-names>P</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Vann</surname><given-names>RR</given-names></name><name><surname>Gonzalez</surname><given-names>P</given-names></name><name><surname>Allingham</surname><given-names>RR</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name></person-group><article-title>Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>146</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18334928</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>AW</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Burdon</surname><given-names>KP</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Baird</surname><given-names>PN</given-names></name><name><surname>Dimasi</surname><given-names>DP</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name></person-group><article-title>Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.</article-title><source>Hum Mol Genet</source><year>2008</year><volume>17</volume><fpage>710</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18037624</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Alward</surname><given-names>WL</given-names></name><name><surname>Kwon</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Streb</surname><given-names>LM</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name><name><surname>Stone</surname><given-names>EM</given-names></name></person-group><article-title>LOXL1 mutations are associated with exfoliation syndrome in patients from the Midwestern United States.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>974</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18036875</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Hau</surname><given-names>VS</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Farhi</surname><given-names>P</given-names></name><name><surname>Katz</surname><given-names>BJ</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Pearson</surname><given-names>E</given-names></name><name><surname>Goldsmith</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Kaminoh</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort.</article-title><source>Cell Cycle</source><year>2008</year><volume>7</volume><fpage>521</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">18287813</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasutto</surname><given-names>F</given-names></name><name><surname>Krumbiegel</surname><given-names>M</given-names></name><name><surname>Mardin</surname><given-names>CY</given-names></name><name><surname>Paoli</surname><given-names>D</given-names></name><name><surname>Lammer</surname><given-names>R</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name></person-group><article-title>Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>1459</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">18385063</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mossbock</surname><given-names>G</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><name><surname>Faschinger</surname><given-names>C</given-names></name><name><surname>Schmut</surname><given-names>O</given-names></name><name><surname>Wedrich</surname><given-names>A</given-names></name><name><surname>Weger</surname><given-names>M</given-names></name></person-group><article-title>Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>857</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">18483563</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramprasad</surname><given-names>VL</given-names></name><name><surname>George</surname><given-names>R</given-names></name><name><surname>Soumittra</surname><given-names>N</given-names></name><name><surname>Sharmila</surname><given-names>F</given-names></name><name><surname>Vijaya</surname><given-names>L</given-names></name><name><surname>Kumaramanickavel</surname><given-names>G</given-names></name></person-group><article-title>Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>318</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">18334947</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Gotoh</surname><given-names>N</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Yoshimura</surname><given-names>N</given-names></name></person-group><article-title>Lysyl Oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese Population.</article-title><source>Am J Ophthalmol</source><year>2008</year><volume>145</volume><fpage>582</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18201684</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Vithana</surname><given-names>EN</given-names></name><name><surname>Yong</surname><given-names>VH</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Mizoguchi</surname><given-names>T</given-names></name><name><surname>Venkatraman</surname><given-names>A</given-names></name><name><surname>Aung</surname><given-names>T</given-names></name></person-group><article-title>Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>3976</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">18450598</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuse</surname><given-names>N</given-names></name><name><surname>Miyazawa</surname><given-names>A</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name><name><surname>Mengkegale</surname><given-names>M</given-names></name><name><surname>Otomo</surname><given-names>T</given-names></name><name><surname>Nishida</surname><given-names>K</given-names></name></person-group><article-title>Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1338</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">18648524</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Matsuda</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Naruse</surname><given-names>S</given-names></name><name><surname>Hitora-Takeshita</surname><given-names>H</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Omi</surname><given-names>N</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Kinoshita</surname><given-names>S</given-names></name></person-group><article-title>LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1037</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">18552979</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Gibson</surname><given-names>J</given-names></name><name><surname>Hutchings</surname><given-names>K</given-names></name><name><surname>Santiago-Turla</surname><given-names>C</given-names></name><name><surname>Wiggs</surname><given-names>JL</given-names></name><name><surname>Budenz</surname><given-names>DL</given-names></name><name><surname>Akafo</surname><given-names>S</given-names></name><name><surname>Challa</surname><given-names>P</given-names></name><name><surname>Herndon</surname><given-names>LW</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name><name><surname>Allingham</surname><given-names>RR</given-names></name></person-group><article-title>Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>3465</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18421074</pub-id></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>KN</given-names></name><name><surname>Kaur</surname><given-names>I</given-names></name><name><surname>Parikh</surname><given-names>RS</given-names></name><name><surname>Mandal</surname><given-names>AK</given-names></name><name><surname>Chandrasekhar</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name></person-group><article-title>The LOXL1 gene variations are not associated with primary open-angle and primary angle-closure glaucomas.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>2343</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18223248</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mabuchi</surname><given-names>F</given-names></name><name><surname>Sakurada</surname><given-names>Y</given-names></name><name><surname>Kashiwagi</surname><given-names>K</given-names></name><name><surname>Yamagata</surname><given-names>Z</given-names></name><name><surname>Iijima</surname><given-names>H</given-names></name><name><surname>Tsukahara</surname><given-names>S</given-names></name></person-group><article-title>Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1303</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18636115</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>WF</given-names></name><name><surname>Chiang</surname><given-names>SW</given-names></name><name><surname>Chen</surname><given-names>LJ</given-names></name><name><surname>Tam</surname><given-names>PO</given-names></name><name><surname>Jia</surname><given-names>LY</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name><name><surname>Geng</surname><given-names>YQ</given-names></name><name><surname>Tham</surname><given-names>CC</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Pang</surname><given-names>CP</given-names></name></person-group><article-title>Evaluation of LOXL1 polymorphisms in primary open-angle glaucoma in southern and northern Chinese.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>2381</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19098994</pub-id></citation></ref><ref id="r35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses.</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">17701901</pub-id></citation></ref><ref id="r36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15297300</pub-id></citation></ref><ref id="r37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>WHAP: haplotype-based association analysis.</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><fpage>255</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17118959</pub-id></citation></ref><ref id="r38"><label>38</label><citation citation-type="web">Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies; 2006. <ext-link ext-link-type="uri" xlink:href="http://hydra.usc.edu/gxe">http://hydra.usc.edu/gxe</ext-link></citation></ref><ref id="r39"><label>39</label><citation citation-type="book">Nei M. Molecular Evolutionary Genetics. New York: Columbia University Press; 1987.</citation></ref><ref id="r40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zietkiewicz</surname><given-names>E</given-names></name><name><surname>Yotova</surname><given-names>V</given-names></name><name><surname>Jarnik</surname><given-names>M</given-names></name><name><surname>Korab-Laskowska</surname><given-names>M</given-names></name><name><surname>Kidd</surname><given-names>KK</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Scozzari</surname><given-names>R</given-names></name><name><surname>Stoneking</surname><given-names>M</given-names></name><name><surname>Tishkoff</surname><given-names>S</given-names></name><name><surname>Batzer</surname><given-names>M</given-names></name><name><surname>Labuda</surname><given-names>D</given-names></name></person-group><article-title>Nuclear DNA diversity in worldwide distributed human populations.</article-title><source>Gene</source><year>1997</year><volume>205</volume><fpage>161</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">9461390</pub-id></citation></ref><ref id="r41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shriver</surname><given-names>MD</given-names></name><name><surname>Kennedy</surname><given-names>GC</given-names></name><name><surname>Parra</surname><given-names>EJ</given-names></name><name><surname>Lawson</surname><given-names>HA</given-names></name><name><surname>Sonpar</surname><given-names>V</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Akey</surname><given-names>JM</given-names></name><name><surname>Jones</surname><given-names>KW</given-names></name></person-group><article-title>The genomic distribution of population substructure in four populations using 8,525 autosomal SNPs.</article-title><source>Hum Genomics</source><year>2004</year><volume>1</volume><fpage>274</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">15588487</pub-id></citation></ref><ref id="r42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsius</surname><given-names>H</given-names></name></person-group><article-title>Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos and Russians.</article-title><source>Trans Ophthalmol Soc U K</source><year>1979</year><volume>99</volume><fpage>296</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">298430</pub-id></citation></ref><ref id="r43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsius</surname><given-names>H</given-names></name></person-group><article-title>Exfoliation syndrome in various ethnic populations.</article-title><source>Acta Ophthalmol Suppl</source><year>1988</year><volume>184</volume><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">2853925</pub-id></citation></ref><ref id="r44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cashwell</surname><given-names>LF</given-names><suffix>Jr</suffix></name><name><surname>Shields</surname><given-names>MB</given-names></name></person-group><article-title>Exfoliation syndrome. Prevalence in a southeastern United States population.</article-title><source>Arch Ophthalmol</source><year>1988</year><volume>106</volume><fpage>335</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3345150</pub-id></citation></ref></ref-list></back></article> 